Without guardrails, employers risk paying top dollar for short-term results
Tirzepatide is a GLP-1 receptor agonist and GIP agonist, meaning it mimics two gut hormones that regulate glucose, insulin, and appetite
Patients with personal or family history of medullary thyroid carcinoma, multiple endocrine neoplasia syndrome type 2, diabetic retinopathy requiring treatment, or severe gastrointestinal disease require careful medical evaluation before initiation
Side Effects of Mounjaro While Mounjaro (Tirzepatide) is an effective treatment for weight management, it is important to be aware of potential side effects, both common and serious
And studies done specifically with women in perimenopause or post-menopause show that tirzpeatide support weight loss and better body composition (smaller waist circumference, which indicates healthier visceral fat levels)
Average weight loss after 48 weeks included: 1 mg dose: about 8.7% body-weight reduction 4 mg dose: about 17.1% reduction 8 mg dose: about 22.8% reduction 12 mg dose: about 24.2% reduction Placebo: about 2.1% reduction These results represented one of the largest average weight reductions reported for an antiobesity medication in a randomized clinical trial
